Covance and Arcinova Providing Integrated Services

Providing integrated services to the global biotech and pharma industry

Covance and Arcinova recently expanded a strategic relationship following the signing of a sales services agreement at the end of 2016. Under the terms of the agreement, Covance is offering Arcinova services alongside its own extensive range of drug development capabilities.

Arcinova is a contract research and development organization based in Alnwick, UK. The Company provides small molecule drug substance, product and analytical support from preclinical through to Phase II. Since its inception in February 2016, Arcinova has built on the legacy customer base developed when it was a Covance site, and is now serving biotechnology and pharmaceutical companies on four continents.

Mark Chadwick, head of business development at Arcinova commented, “We are thrilled to be developing this key strategic relationship with Covance. The resources they can bring to bear and the strength of their integrated offering is proving attractive to our customer base. We look forward to a long and productive relationship.”

Mark is Arcinova’s client liaison manager for the collaboration.

Arcinova enables expanded scientific depth and capabilities for Covance. Recently, a US biotech client was struggling to find a supplier who could deliver on a challenging API synthesis job. Covance engaged Arcinova expert scientists who helped to solve the chemistry issue. The combined Covance/Arcinova team is now working with the client on an ongoing basis.

David Lankester, executive director, business development at Covance commented, “We are delighted that our relationship with Arcinova enables us to expand our strategic, efficient and integrated services offerings, such as Early Phase Development Solutions (EPDS) to our biopharmaceutical clients.”

David Lankester is Covance’s client liaison manager for the collaboration.

About Arcinova
The team at Arcinova is focused on process, research, development, scale-up and small scale manufacturing, including bioanalysis, DMPK, regulatory and consulting services, covering drug candidates in development and launched to the Market.

The Arcinova mission is to deliver best in class technology services in the fields of contract research, development and small scale manufacturing to maximize effectiveness whilst minimizing risk and overall cost.

Visit Covance.com to learn more about how partnering with Covance can benefit you.